We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Monster Beverage
MNST
$88.5B
| $82.8M | 0.51% |
3,588,894
-178,470
| -5% | -$3.74M |
|
52
iShares MSCI EAFE ETF
EFA
$80.2B
| $81.4M | 0.5% |
1,268,751
+88,903
| +8% | +$5.6M |
|
53
Procter & Gamble
PG
$339B
| $80.5M | 0.5% |
+982,527
| New | +$84.5M |
|
54
Lam Research
LRCX
$390B
| $80.4M | 0.5% |
11,450,500
+4,571,690
| +66% | +$36.1M |
|
55
SAP
SAP
$238B
| $80M | 0.49% |
1,108,339
-394,668
| -26% | -$27M |
|
56
UnitedHealth
UNH
$370B
| $76.2M | 0.47% |
644,484
-1,187,476
| -65% | -$132M |
|
57
American Tower
AMT
$80.4B
| $75.1M | 0.46% |
797,454
+25,071
| +3% | +$2.44M |
|
58
Xerox
XRX
$425M
| $74.7M | 0.46% |
2,206,121
+142,847
| +7% | +$5.04M |
|
|
RAD
59
DELISTED
Rite Aid Corporation
RAD
| $70M | 0.43% |
402,567
-18,321
| -4% | -$2.85M |
|
|
CHL
60
DELISTED
China Mobile Limited
CHL
| $69.7M | 0.43% |
1,071,974
+966,219
| +914% | +$63.1M |
|
61
Edwards Lifesciences
EW
$51.7B
| $67.9M | 0.42% |
2,857,800
+2,298,528
| +411% | +$51.6M |
|
|
FSL
62
DELISTED
FREESCALE SEMICONDUCTOR LTD
FSL
| $66.5M | 0.41% |
1,631,985
+998,402
| +158% | +$34.4M |
|
|
ALU
63
DELISTED
Alcatel-Lucent
ALU
| $66.1M | 0.41% |
17,717,746
+3,838,792
| +28% | +$14.1M |
|
64
Allstate
ALL
$67.5B
| $65.7M | 0.4% |
923,077
-427,781
| -32% | -$30.2M |
|
|
BRCM
65
DELISTED
BROADCOM CORP CL-A
BRCM
| $63.6M | 0.39% |
1,469,891
-51,999
| -3% | -$2.27M |
|
66
Mastercard
MA
$493B
| $61.6M | 0.38% |
712,902
-220,779
| -24% | -$19.2M |
|
|
ARMH
67
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $61.2M | 0.38% |
1,241,782
+902,940
| +266% | +$44.9M |
|
68
Sony
SONY
$138B
| $59.4M | 0.37% |
11,089,240
+543,985
| +5% | +$2.75M |
|
|
69
TSMC
TSM
$2.18T
| $58.1M | 0.36% |
2,474,821
-7,952,249
| -76% | -$187M |
|
70
Cigna
CI
$74.6B
| $57.9M | 0.36% |
447,592
-544,573
| -55% | -$63.3M |
|
71
Burlington
BURL
$23.2B
| $57.7M | 0.36% |
971,580
+50,709
| +6% | +$2.72M |
|
72
MetLife
MET
$62.1B
| $57.1M | 0.35% |
1,268,096
-1,069,794
| -46% | -$48.1M |
|
73
AvalonBay Communities
AVB
$26.8B
| $56.6M | 0.35% |
324,757
+73,325
| +29% | +$12.7M |
|
74
BlackBerry
BB
$5.26B
| $56.3M | 0.35% |
6,312,722
+3,257,573
| +107% | +$33.1M |
|
|
CY
75
DELISTED
Cypress Semiconductor
CY
| $55M | 0.34% |
3,898,411
+3,843,822
| +7,041% | +$56.9M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.